Your browser doesn't support javascript.
loading
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
Hendricks, Linda A J; Hoogerbrugge, Nicoline; Mensenkamp, Arjen R; Brunet, Joan; Lleuger-Pujol, Roser; Høberg-Vetti, Hildegunn; Tveit Haavind, Marianne; Innella, Giovanni; Turchetti, Daniela; Aretz, Stefan; Spier, Isabel; Tischkowitz, Marc; Jahn, Arne; Links, Thera P; Olderode-Berends, Maran J W; Blatnik, Ana; Leter, Edward M; Evans, D Gareth; Woodward, Emma R; Steinke-Lange, Verena; Anastasiadou, Violetta C; Colas, Chrystelle; Villy, Marie-Charlotte; Benusiglio, Patrick R; Gerasimenko, Anna; Barili, Valeria; Branchaud, Maud; Houdayer, Claude; Tesi, Bianca; Yazicioglu, M Omer; van der Post, Rachel S; Schuurs-Hoeijmakers, Janneke H M; Vos, Janet R.
Affiliation
  • Hendricks LAJ; Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud university medical center, Nijmegen, the Netherlands.
  • Hoogerbrugge N; Radboud university medical center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
  • Mensenkamp AR; Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud university medical center, Nijmegen, the Netherlands.
  • Brunet J; Radboud university medical center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
  • Lleuger-Pujol R; Department of Human Genetics, Radboudumc Expert Center for PHTS, Radboud university medical center, Nijmegen, the Netherlands.
  • Høberg-Vetti H; Radboud university medical center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
  • Tveit Haavind M; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona, Spain.
  • Innella G; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona, Spain.
  • Turchetti D; Western Norway Familial Cancer Center, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Aretz S; Western Norway Familial Cancer Center, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Spier I; Department of Medical and Surgical Sciences, Center for Studies on Hereditary Cancer, University of Bologna and Unit of Medical Genetics, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Tischkowitz M; Department of Medical and Surgical Sciences, Center for Studies on Hereditary Cancer, University of Bologna and Unit of Medical Genetics, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Jahn A; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
  • Links TP; Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
  • Olderode-Berends MJW; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.
  • Blatnik A; Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
  • Leter EM; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
  • Evans DG; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Woodward ER; Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.
  • Steinke-Lange V; German Cancer Consortium (DKTK), Dresden, Germany.
  • Anastasiadou VC; National Center for Tumor Diseases (NCT), Partner Site Dresden, Dresden, Germany.
  • Colas C; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Villy MC; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Benusiglio PR; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Gerasimenko A; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Barili V; Manchester Centre for Genomic Medicine, St Mary's Hospital, Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK.
  • Branchaud M; Manchester Centre for Genomic Medicine, St Mary's Hospital, Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK.
  • Houdayer C; Medical Genetics Center, Munich, Germany.
  • Tesi B; Arbeitsgruppe Erbliche Gastrointestinale Tumore, Medizinische Klinik und Poliklinik IV-Campus Innenstadt, Klinikum der Universität München, Munich, Germany.
  • Yazicioglu MO; Karaiskakio Foundation, Nicosia Cyprus and Archbishop Makarios III Children's Hospital, Nicosia, Cyprus.
  • van der Post RS; Institut Curie, Service de Génétique, Paris, France.
  • Schuurs-Hoeijmakers JHM; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe Labellisée Par la Ligue Nationale Contre le Cancer, Paris, France.
  • Vos JR; UF d'oncogénétique Clinique, Department de Génétique, Hôspital Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France.
J Natl Cancer Inst ; 115(1): 93-103, 2023 01 10.
Article in En | MEDLINE | ID: mdl-36171661
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hamartoma Syndrome, Multiple / Thyroid Neoplasms / Kidney Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Netherlands Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hamartoma Syndrome, Multiple / Thyroid Neoplasms / Kidney Neoplasms Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Netherlands Country of publication: United States